IP Verse

Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy

Patent No. EP3363433 (titled "Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy") was filed by Amarin Pharmaceuticals Ireland on Jun 28, 2013. The application was issued on Dec 9, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLESep 9, 2021HOFFMANN EITLE
COOKESep 7, 2021ELKINGTON AND FIFE
ELKINGTON AND FIFESep 3, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3363433

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP17206714A
Filing Date
Jun 28, 2013
Status
Granted And Under Opposition
Nov 6, 2020
Publication Date
Dec 9, 2020
External Links
Slate, Register , Google Patents